BLM gene mutations are known to be associated with increased risk of developing multiple cancers including breast (Kluzniak et al., 2019), colorectal cancers (de Voer et al., 2015) and endometrial cancer (Long et al., 2019) which is consistent with our findings and support the pathogenicity of the identified variant. This evidence concerns the gene BLM and colorectal cancer.